TickerKhojITI Mutual Fund · Equity · Sectoral / Thematic · Direct plan
ITI Pharma and Healthcare Fund - Direct Plan - Growth
₹19.4995NAV on 2 Nov 2026Expense ratio 0.86%
3 Nov 2025NAV low 15.79 · high 20.32+9.1%
In plain words
Over 3 years it returned +20.0% a year, against +8.0% for its benchmark index.
Its worst fall from a peak in the last 3 years was -17.1%.
On 3-year return it ranks 20 of 139 funds in Sectoral / Thematic.
A monthly SIP over 3 years ended ₹12,658 higher in the direct plan than the regular plan, because of the lower expense ratio.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | +0.4% | +4.6% |
| 3 months | -1.1% | -3.8% |
| 6 months | +11.9% | -1.6% |
| 1 year | +10.3% | -8.1% |
| 3 years (yearly) | +20.0% | +8.0% |
| Since start (yearly) | +14.3% | +11.3% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,31,077 | +17.4% |
| 3 years | ₹3,60,000 | ₹4,30,471 | +11.9% |
Other plan of this fund: ITI Pharma and Healthcare Fund - Regular Plan - Growth